Trial Profile
A Phase 4 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Efficacy And Safety Of Re-Treatment With Varenicline In Subjects Who Are Currently Smoking, And Who Have Previously Taken Varenicline
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Sponsors Pfizer
- 06 Nov 2015 New trial record